University of California, San Francisco (UCSF)
About University of California, San Francisco (UCSF)
Check out the link below for more information on biotechnolgy-related research at UCSF.589 articles with University of California, San Francisco (UCSF)
-
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
-
When Becky Fu met Brett Robb at a CRISPR conference four years ago, they were both deeply involved in CRISPR. The two published a paper in March in Nature Microbiology on the subject and on Fu’s findings on the complex mechanisms of the Cpf1 nucleases, a different set of enzymes than the often-us...
-
Recently, we interviewed Bill Lindstaedt, who is the Assistant Vice Chancellor of Career Advancement, International and Postdoctoral Services at the University of California San Francisco. If you’ve ever wanted more information from an expert on careers in the life sciences, reviewing his career ...
-
AFM, a polio-like condition, has infected more than 500 children since 2014. Scientists may have discovered the root of the disease.
-
Here are some of the top research stories that happened around the industry this week.
-
Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers
5/1/2019
Collaboration will broaden Tmunity’s pipeline to include a glioma T cell therapy engineered to express a newly discovered T cell receptor
-
Researchers with the University of California San Francisco (UCSF) developed a “neural decoder” that translates brain activity to synthesize audible speech. They published their research in the journal Nature.
-
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
-
April 11 is World Parkinson’s Day, designed to raise awareness of Parkinson’s disease. Parkinson’s is a progressive disease of the nervous system that affects movement.
-
Since Biogen and Tokyo-based Eisai recently reported a massive failure in Alzheimer’s research for their drug aducanumab, scientists and industry watchers are scanning the tea leaves looking for other potential approaches to treating the disease. One that is of interest is a hormone called Klotho.
-
When it comes to biotech and pharma innovation few places stand out like the Biotech Bay. The area is home to a plethora of innovative companies that are shaping the future of medical treatment for a variety of diseases and conditions on a daily basis.
-
Research Roundup: Gene Therapy for Deafness, Autism Genes, Breakthroughs in Parkinson’s and ALS, ...
3/1/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Cancer Research UK, a cancer research and awareness charity in the United Kingdom and Isle of Man, recently announced its latest Grand Challenge winners. This cancer research grant awards a series of £20 million wards to international, multidisciplinary teams that focus on unique and new approach...
-
January 18 Research Roundup: Skin Cancer, Turning Cancer Cells Into Fat Cells, and a Longevity Test
1/18/2019
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
As the Trump administration has continued to show its lack of financial support of scientific research using fetal tissue, the National Institutes of Health is setting aside $20 million to fund research that could develop alternatives to the use of embryonic tissue.
-
Political Battle Over Fetal Tissue Could Force Closure of Research Center Pivotal to HIV Therapies
12/6/2018
Researchers who focus on HIV vaccines are caught in the middle of a political battle over funding of fetal stem cell research. -
New research is shedding some light on how the brain responds when people are feeling sad, which could lead to new methods of treating some mood disorders. A research team from the University of California, San Francisco (UCSF) reported in an article in Cell that a network defined by amygdala-hip...
-
Genentech, a Roche company, released data from a long-term clinical trial of Ocrevus in multiple sclerosis. Meanwhile, Novartis isn’t standing still on MS. Earlier this week the company announced that both the FDA and EMA had accepted its NDA and MAA, respectively, for siponimod.
-
Celgene Corporation presented data at the 34th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) held in Berlin, Germany with results from two Phase III trials.
-
A new biopharmaceutical company known as Sitryx launched with $30 million in a Series A funding round to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation.